ArticleCancer biology & therapy2024

RND1 inhibits epithelial-mesenchymal transition and temozolomide resistance of glioblastoma via AKT/GSK3-β pathway.

Qian Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.